Literature DB >> 7184757

Epidemic dengue fever caused by dengue type 2 virus in Kenya: preliminary results of human virological and serological studies.

B K Johnson, D Ocheng, A Gichogo, M Okiro, D Libondo, P Kinyanjui, P M Tukei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7184757

Source DB:  PubMed          Journal:  East Afr Med J        ISSN： 0012-835X


× No keyword cloud information.
  21 in total

1.  The plasma virome of febrile adult Kenyans shows frequent parvovirus B19 infections and a novel arbovirus (Kadipiro virus).

Authors:  Carolyne N Ngoi; Juliana Siqueira; Linlin Li; Xutao Deng; Peter Mugo; Susan M Graham; Matt A Price; Eduard J Sanders; Eric Delwart
Journal:  J Gen Virol       Date:  2016-10-24       Impact factor: 3.891

2.  Dengue and West Nile Virus Transmission in Children and Adults in Coastal Kenya.

Authors:  David M Vu; Tamara Banda; Crystal Y Teng; Chelsea Heimbaugh; Eric M Muchiri; Peter L Mungai; Francis M Mutuku; Julie Brichard; Ginny Gildengorin; Erin M Borland; Ann M Powers; Uriel Kitron; Charles H King; A Desiree LaBeaud
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

3.  Clinical and Epidemiological Characterization of the First Recognized Outbreak of Dengue Virus-Type 2 in Mozambique, 2014.

Authors:  Marilia Massangaie; Gabriela Pinto; Fernando Padama; Geraldo Chambe; Mariana da Silva; Inocêncio Mate; Celia Chirindza; Sadia Ali; Sãozinha Agostinho; Daniel Chilaule; Jacqueline Weyer; Chantel le Roux; Ana Paula Abilio; Cynthia Baltazar; Timothy J Doyle; Julie Cliff; Janusz Paweska; Eduardo Samo Gudo
Journal:  Am J Trop Med Hyg       Date:  2015-12-07       Impact factor: 2.345

Review 4.  Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease.

Authors:  Scott C Weaver; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2009-02-13       Impact factor: 3.342

5.  Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa.

Authors:  M Bourgarel; N Wauquier; J-P Gonzalez
Journal:  Emerg Health Threats J       Date:  2010-06-03

6.  Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study.

Authors:  Luke E Mease; Rodney L Coldren; Lillian A Musila; Trish Prosser; Fredrick Ogolla; Victor O Ofula; Randal J Schoepp; Cindy A Rossi; Nicholas Adungo
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

7.  An improved odor bait for monitoring populations of Aedes aegypti-vectors of dengue and chikungunya viruses in Kenya.

Authors:  Eunice A Owino; Rosemary Sang; Catherine L Sole; Christian Pirk; Charles Mbogo; Baldwyn Torto
Journal:  Parasit Vectors       Date:  2015-04-29       Impact factor: 3.876

8.  Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007.

Authors:  Caroline Ochieng; Petronella Ahenda; Amy Y Vittor; Raymond Nyoka; Stella Gikunju; Cyrus Wachira; Lilian Waiboci; Mamo Umuro; Andrea A Kim; Leonard Nderitu; Bonventure Juma; Joel M Montgomery; Robert F Breiman; Barry Fields
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

9.  A household serosurvey to estimate the magnitude of a dengue outbreak in Mombasa, Kenya, 2013.

Authors:  Esther M Ellis; John C Neatherlin; Mark Delorey; Melvin Ochieng; Abdinoor Haji Mohamed; Daniel Ondari Mogeni; Elizabeth Hunsperger; Shem Patta; Stella Gikunju; Lilian Waiboic; Barry Fields; Victor Ofula; Samson Limbaso Konongoi; Brenda Torres-Velasquez; Nina Marano; Rosemary Sang; Harold S Margolis; Joel M Montgomery; Kay M Tomashek
Journal:  PLoS Negl Trop Dis       Date:  2015-04-29

10.  Vector competence of Aedes aegypti populations from Kilifi and Nairobi for dengue 2 virus and the influence of temperature.

Authors:  Edith Chepkorir; Joel Lutomiah; James Mutisya; Francis Mulwa; Konongoi Limbaso; Benedict Orindi; Zipporah Ng'ang'a; Rosemary Sang
Journal:  Parasit Vectors       Date:  2014-09-15       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.